Interview with Phil Reason,
Instem CEO

Investor Meet Company: Results and Company Update
April 2022

Presentation now available to watch on-demand

Watch Now

A global provider of leading software solutions
and services to the life sciences community.

Helping our clients bring life enhancing products to market faster.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.

Latest News

17 May 2022 - Notice of AGM

Read More

03 May 2022 - European Medicines Agency Research Grant

Read More

26 April 2022 - Unaudited Results for the Year Ended 31 December 2021 & Investor Presentation

Read More

Annual Report 2020

FY21: Strong financial performance, strategic transformation

Annual Report 2021

Our achievements and performance in 2021 have been exceptional and we have accomplished a fundamental strategic shift in scale and reach having completed three important acquisitions.

FY21: Strong financial performance, strategic transformation

Research Note by Gareth Evans of Progressive Equity Research